HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases HiFiBiO Therapeutics, a ...

Your Grandma, neighbor, or nephew asks you “What do you study? Why does it matter?” What would your response be in 3 minutes or less with no slides to demonstrate or explain (Props are acceptable)?

The field of systems immunology and translational research in infectious diseases has seen significant advancements due to ...

Co announces the publication of a new discovery of the properties of Curaxin CBLC102 (Quinacrine), CBLI's lead anti-cancer drug candidate, in the current edition of the European Journal of Immunology.

Once again, AbbVie dominates doctors’ ranking of makers of immunology meds. Just like last year, the Skyrizi and Rinvoq maker scored the highest by far in ZoomRx’s analysis of how healthcare providers ...